Nothing is wrong with earnings, they're great. Pipeline is as about as good as it has ever been. Growth is stellar, as usual. Cypher is getting its just deserts, as it should. MDT has a stent, so what? Nothing is wrong. Whenever SRDX gets unfairly slammed you just buy more and sit pretty. It's that simple. Don't worry, just buy under 40 and be happy. Ask the wifinater. She knows a good buy. S&P has been way off all along. They don't like high PE (above S&P average) stocks and try to find some surface reasons to bash. That's about all they can do. Management concerns? Like real voodoo analysis, man. Clutching for straws. Their arguments don't hold water; they suck like mad. Just laugh at them and buy more SRDX. Add to the core and hold is my motto. JMHO.